2 'undervalued' ASX 200 shares to 'beat market' before everyone else wakes up

Here are two businesses with excellent long-term potential that you could buy for cheap right now.

| More on:
a smiling woman holds up two fingers and winks.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The last 18 months has demonstrated that it's now more important than ever to ignore short-term volatility and instead focus on the long-term prospects of a business.

There are no better examples of that thinking than these two S&P/ASX 200 Index (ASX: XJO) examples, which Seneca Financial Solutions investment advisor Arthur Garipoli rates as buys:

'Positive view' on health devices giant

Healthcare is one of those industries that don't fare too badly even through times of economic stress.

That's because people will, understandably, prioritise their physical and mental wellbeing over other goods and services.

As such, a leader in its field like Resmed CDI (ASX: RMD) makes a sensible buy.

"This manufacturer of medical devices for respiratory disorders recently reported results that beat market expectations," Garipoli told The Bull.

"Revenue of US$1.0337 billion for the three months ending on December 31, 2022 was up 16% on the prior corresponding period."

The hardware company did encounter some roadblocks to growth last year as a global computer chip shortage hampered its own production.

But that short-term issue, Garipoli feels, is now past it.

"We retain a positive view on RedMed, given an improving supply chain," he said.

"It will enable ResMed to meet additional demand for respiratory units, leading to revenue growth."

The ResMed share price is 8.9% up over the past year.

Excellent dividend yield plus cheap share price

Deterra Royalties Ltd (ASX: DRR) is a mining royalty company, meaning it's almost like a landlord collecting rent from sites where resource companies are operating.

This model has some advantages over directly owning mining shares, according to Garipoli.

"Deterra holds a 1.232% royalty in BHP Group Ltd (ASX: BHP)'s Mining Area C (MAC) involving iron ore operations in the Pilbara region of Western Australia," he said.

"It gives Deterra price and volume exposure to a world class asset without taking on mining risk."

Garipoli noted that the first half update showed BHP increasing production at the MAC site.

"We believe the stock is undervalued due to the quality of the asset, its discount to peers and providing investors with a forecast fully franked dividend yield of 6.6%."

The Deterra share price has remained flat over the past year and so far in 2023.

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.
Financial Shares

'Strong momentum': 2 ASX financial shares backed by top fundie for 2025

ASX financial shares had a strong trading session on Tuesday with several new price records set.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Broker Notes

The best Australian shares to buy with $7,000 right now

Analysts think these shares could give you a good return on investment.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Broker Notes

Top broker says buy ResMed and this ASX 200 share

Ord Minnett was impressed with their quarterly updates from last month.

Read more »

A young woman makes an online travel booking as she sits on some steps with her suitcase next to her.
Broker Notes

2 ASX All Ords shares just upgraded by top brokers (one with 44% upside!)

Leading brokers forecast some outsized gains ahead for these two ASX All Ords shares.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Guess which ASX 200 share Goldman Sachs says is a buy

Let's see which stock is being tipped as a buy by analysts.

Read more »

A female executive smiles as she carries out business on her mobile phone.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »

A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »